208 related articles for article (PubMed ID: 32163755)
1. Anxiety in Argentinian patients with multiple sclerosis: Prevalence and associated factors.
Chertcoff A; Curbelo MC; Bauer J; Ferrandina F; Martinez A; Steinberg J; Carrá A
Mult Scler Relat Disord; 2020 Jun; 41():102042. PubMed ID: 32163755
[TBL] [Abstract][Full Text] [Related]
2. The prevalence of anxiety and associated factors in persons with multiple sclerosis.
Pham T; Jetté N; Bulloch AGM; Burton JM; Wiebe S; Patten SB
Mult Scler Relat Disord; 2018 Jan; 19():35-39. PubMed ID: 29125968
[TBL] [Abstract][Full Text] [Related]
3. In multiple sclerosis anxiety, not depression, is related to gender.
Théaudin M; Romero K; Feinstein A
Mult Scler; 2016 Feb; 22(2):239-44. PubMed ID: 26041798
[TBL] [Abstract][Full Text] [Related]
4. Features of sleep disturbances in multiple sclerosis patients.
Leonavicius R; Adomaitiene V
Psychiatr Danub; 2014 Sep; 26(3):249-55. PubMed ID: 25191772
[TBL] [Abstract][Full Text] [Related]
5. Anxiety and depression in multiple sclerosis patients around diagnosis.
Giordano A; Granella F; Lugaresi A; Martinelli V; Trojano M; Confalonieri P; Radice D; Solari A;
J Neurol Sci; 2011 Aug; 307(1-2):86-91. PubMed ID: 21621796
[TBL] [Abstract][Full Text] [Related]
6. Depression, anxiety, and fear of COVID-19 in patients with multiple sclerosis in pandemic era: a cross-sectional study.
Alirezaei M; Eskandarieh S; Sahraian MA; Naser Moghadasi A
Neurol Sci; 2022 Jan; 43(1):59-66. PubMed ID: 34554334
[TBL] [Abstract][Full Text] [Related]
7. Fatigue and its association with sleep disorders, depressive symptoms and anxiety in patients with multiple sclerosis.
Labuz-Roszak B; Kubicka-Bączyk K; Pierzchała K; Machowska-Majchrzak A; Skrzypek M
Neurol Neurochir Pol; 2012; 46(4):309-17. PubMed ID: 23023429
[TBL] [Abstract][Full Text] [Related]
8. Depressive Symptoms Are Associated With More Negative Functional Outcomes Than Anxiety Symptoms in Persons With Multiple Sclerosis.
Gill S; Santo J; Blair M; Morrow SA
J Neuropsychiatry Clin Neurosci; 2019; 31(1):37-42. PubMed ID: 30187820
[TBL] [Abstract][Full Text] [Related]
9. Anxiety and depression in Nepal: prevalence, comorbidity and associations.
Risal A; Manandhar K; Linde M; Steiner TJ; Holen A
BMC Psychiatry; 2016 Apr; 16():102. PubMed ID: 27075664
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and correlates of depression and anxiety disorder in a sample of inmates in a Nigerian prison.
Osasona SO; Koleoso ON
Int J Psychiatry Med; 2015; 50(2):203-18. PubMed ID: 26475685
[TBL] [Abstract][Full Text] [Related]
11. Comorbidities of psychiatric and headache disorders in Nepal: implications from a nationwide population-based study.
Risal A; Manandhar K; Holen A; Steiner TJ; Linde M
J Headache Pain; 2016; 17():45. PubMed ID: 27102122
[TBL] [Abstract][Full Text] [Related]
12. Magnitude and concurrence of anxiety and depression among attendees with multiple sclerosis at a tertiary care Hospital in Oman.
Al-Asmi A; Al-Rawahi S; Al-Moqbali ZS; Al-Farsi Y; Essa MM; El-Bouri M; Koshy RP; Gujjar AR; Jacob PC; Al-Hodar A; Al Adawi S
BMC Neurol; 2015 Aug; 15():131. PubMed ID: 26242758
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, symptom patterns and comorbidity of anxiety and depressive disorders in primary care in Qatar.
Bener A; Ghuloum S; Abou-Saleh MT
Soc Psychiatry Psychiatr Epidemiol; 2012 Mar; 47(3):439-46. PubMed ID: 21293844
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of poor sleep quality and its association with depression and anxiety scores in patients admitted for cardiovascular disease: A cross-sectional designed study.
Matsuda R; Kohno T; Kohsaka S; Fukuoka R; Maekawa Y; Sano M; Takatsuki S; Fukuda K
Int J Cardiol; 2017 Feb; 228():977-982. PubMed ID: 27915216
[TBL] [Abstract][Full Text] [Related]
15. Mental Health Comorbidity in MS: Depression, Anxiety, and Bipolar Disorder.
Turner AP; Alschuler KN; Hughes AJ; Beier M; Haselkorn JK; Sloan AP; Ehde DM
Curr Neurol Neurosci Rep; 2016 Dec; 16(12):106. PubMed ID: 27848174
[TBL] [Abstract][Full Text] [Related]
16. Fear and anxiety in patients with multiple sclerosis during COVID-19 pandemic; report of an Iranian population.
Ramezani N; Ashtari F; Bastami EA; Ghaderi K; Hosseini SM; Naeini MK; Rajabi F; Adibi I
Mult Scler Relat Disord; 2021 May; 50():102798. PubMed ID: 33571791
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Depression, Anxiety, and Quality of Life in Singaporean Patients With Glaucoma.
Lim NC; Fan CH; Yong MK; Wong EP; Yip LW
J Glaucoma; 2016 Jul; 25(7):605-12. PubMed ID: 26950574
[TBL] [Abstract][Full Text] [Related]
18. Differences in the burden of psychiatric comorbidity in MS vs the general population.
Marrie RA; Fisk JD; Tremlett H; Wolfson C; Warren S; Tennakoon A; Leung S; Patten SB;
Neurology; 2015 Dec; 85(22):1972-9. PubMed ID: 26519542
[TBL] [Abstract][Full Text] [Related]
19. The Prevalence of Pain in Adults with Multiple Sclerosis: A Multicenter Cross-Sectional Survey.
Drulovic J; Basic-Kes V; Grgic S; Vojinovic S; Dincic E; Toncev G; Kezic MG; Kisic-Tepavcevic D; Dujmovic I; Mesaros S; Miletic-Drakulic S; Pekmezovic T
Pain Med; 2015 Aug; 16(8):1597-602. PubMed ID: 26087108
[TBL] [Abstract][Full Text] [Related]
20. Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data.
Marrie RA; Walld R; Bolton JM; Sareen J; Walker JR; Patten SB; Singer A; Lix LM; Hitchon CA; El-Gabalawy R; Katz A; Fisk JD; Bernstein CN;
BMC Res Notes; 2017 Nov; 10(1):619. PubMed ID: 29178935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
